Pavitra Keshavan 25th International Pathogenic Neisseria Conference 2026

Abstracts this author is presenting:

• Safety, effectiveness, and immunogenicity of meningococcal combined MenACWY-7B vaccine in healthy adolescents and adults: a randomized, controlled, partially blinded phase 1/2 study — Poster Session B
• Safety, tolerability, and immunogenicity of meningococcal combined MenACWY-7B vaccine in healthy infants: a randomized, partially blinded phase 2 study — Poster Session A
• A single adolescent dose of 4CMenB effectively boosts immune responses up to 19 years after priming in infancy: Results from a phase 3b, open-label, multicenter study — Session 13 - Meningococcal Vaccines